Herbert Markley, MD
Basic profileUniversity of Massachusetts Chan Medical School
Herbert Markley is a Neurology physician affiliated with University of Massachusetts Chan Medical School. OpenAlex indexes 28 publications with 1,280 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
3 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
55.5%Neuromuscular Blocker54%Onabotulinumtoxina95%Botox5%Part D + Part B≥29 patientsCentral alpha-2 Adrenergic Agonist0.6%Tizanidine Hcl100%Part D<11 patients+ 2 more classes in this area
Nervous system
36.8%Calcitonin gene-related peptide (CGRP) antagonists8.3%Emgality Pen35%Ajovy Autoinjector25%Emgality Syringe19%Aimovig Autoinjector12%Ajovy Syringe9%Part D<11 patientsSerotonin-1b and Serotonin-1d Receptor Agonist6.7%Rizatriptan39%Sumatriptan Succinate26%Naratriptan Hcl18%Zolmitriptan8%Eletriptan Hbr6%Zomig3%Part D<11 patients+ 14 more classes in this area
Metabolism & gastrointestinal
3.3%Serotonin-3 Receptor Antagonist2.7%Ondansetron Hcl90%Ondansetron Odt10%Part D<11 patientsCorticosteroid0.6%Prednisone100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Editorial for Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know
Headache The Journal of Head and Face Pain
2015 - New Daily Persistent Headache and Potential New Therapeutic Agents
Current Neurology and Neuroscience Reports
2014 - Real-world Experience With Once-daily Gabapentin for the Treatment of Postherpetic Neuralgia (PHN)
Clinical Journal of Pain
2014 - CoEnzyme Q10 and Riboflavin: The Mitochondrial Connection
Headache The Journal of Head and Face Pain
2012 - Defining Refractory Migraine: Results of the RHSIS Survey of American Headache Society Members
Headache The Journal of Head and Face Pain
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Joel Gore, MD
University of Massachusetts Chan Medical School
Johanna Seddon, MD
University of Massachusetts Chan Medical School
Stuart Levitz, MD
University of Massachusetts Chan Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”